Novartis bags USFDA accelerated approval for Fabhalta for reduction of proteinuria in primary IgA nephropathy Ruchika Sharma8 Aug 2024 11:30 AM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta (iptacopan), a...
Corticosteroids use reduces proteinuria but fails to delay ESKD in immunoglobulin A nephropathy: Study Medha Baranwal15 March 2024 8:45 PM ISTNorway: In a cohort of Norwegian patients with immunoglobulin A nephropathy (IgAN), a recent retrospective cohort study showed no impact of...
Prednisone combined with mycophenolate mofetil effective in Immunoglobulin A nephropathy with Renal Dysfunction Dr Kartikeya Kohli2 Jan 2024 9:00 PM ISTA recent study identified a promising treatment for Immunoglobulin A Nephropathy (IgAN), a prevalent form of chronic glomerulonephritis which is a...
Mycophenolate mofetil-based regimen as effective as conventional steroids therapy in immunoglobulin A nephropathy Aditi7 Dec 2023 10:45 AM ISTImmunoglobulin A nephropathy (IgAN) is the most prevalent type of primary glomerulonephritis. Approximately 30% of patients with IgAN will develop...
Fluticasone propionate aerosol combined with ACEI/ARB reduces proteinuria in Immunoglobulin A nephropathy Aditi1 Aug 2023 8:00 PM ISTChina: According to a study published in BMC Nephrology, researchers have concluded that Fluticasone propionate aerosol combined with...
